The Ohio State University Wexner Medical Center’s Heart and Vascular Center has named Dr. Dan Roden, senior vice president for Personalized Medicine at Vanderbilt University Medical Center, as recipient of the 2019 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.
A new 15-year study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that patients with peripheral arterial disease may not be prescribed life-saving medications at the same rate as for other heart conditions.
Should you take omega-3 pills? Or try to have two to servings of omega-3 rich fish a week, as the American Heart Association recommends? It may seem a bit murky if you follow headlines about nutrition and health. That’s why researchers at the Intermountain Healthcare Heart Institute continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.
Researchers from the Intermountain Healthcare Heart Institute in Salt Lake City have identified new mutations in a gene commonly associated with non-ischemic dilated cardiomyopathy (NIDC), a disease that weakens the heart muscle, making it more difficult to adequately circulate blood to meet the body’s needs.
The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects. A study leader says the physiologic benefits represent a milestone in pediatric cardiology.
Experts from 80 medical centers in the U.S., Canada and Norway will convene Nov. 15–17 in Baltimore, Maryland, to share best practices and performance improvement initiatives designed to reduce unnecessary tests, treatments and procedures and improve the overall value of health care.
Women who are diagnosed with peripartum cardiomyopathy (PPCM) during late pregnancy or within a month following delivery are more likely to experience restored cardiac function and improved outcomes compared to those who are diagnosed later in the postpartum period.
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019.
The Enhanced Lifestyles for Metabolic Syndrome (ELM) Trial, a multisite test of two lifestyle treatments for a dangerous cluster of sub-disease indicators called the metabolic syndrome, is now accepting applicants at five medical centers around the country.
Faculty from Beth Israel Deaconess Medical Center’s (BIDMC) CardioVascular Institute and colleagues will be presenting new advances and research at the 2019 American Heart Association (AHA) Scientific Sessions.
The success of antiretroviral therapies has extended the lives of people living with HIV, long enough for other chronic health conditions to emerge, including a recently documented uptick in sudden death.
In a new study presented to heart specialists from around the world, researchers at the Intermountain Healthcare Heart Institute in Salt Lake City found that simple “nudges” in the form of texts, emails and phone calls, not only help patients fill that first statin prescription, but also continue to help them take their medications over the long term.
Researchers at University of California San Diego School of Medicine, as well as a diverse team of cardiologists and physicists, developed a machine learning algorithm to predict the life expectancy in heart failure patients.
If you're looking for health and fitness story ideas, view these research highlights from Exercise and Sport Sciences Reviews and Medicine & Science in Sports & Exercise®, ACSM’s flagship journal.
Taller people have an increased risk of developing atrial fibrillation, according to a new Penn Medicine study. The research is the among the first to demonstrate that height may be a causal—not correlated—risk factor for AFib.
Analysis of more than 29,000 adults listed on the national heart transplant registry from 2006 to 2015 shows how rules that give hospitals discretion in determining who gets a transplant result in large discrepancies in how sick patients are when they receive heart transplants at hospitals across the United States.
Preventive cardiology researchers at UT Southwestern Medical Center believe that a new blood test for protein biomarkers could identify early stage heart disease in people.
A new study from researchers at the Smidt Heart Institute at Cedars-Sinai shows that electronic nicotine delivery systems, including devices such as e-cigarettes, may be just as harmful to the heart, if not more, than traditional cigarettes. Downloadable video is available.
New research from The Ohio State University Wexner Medicine Center identifies a gap in doctor knowledge and understanding of hair care as a barrier to exercise among African American female patients.
A first-of-its-kind study led by researchers at Washington State University shows that new cases of heart disease among American Indians in three U.S. regions have gone down. Findings from the study
Regular exercise protects the cardiovascular system by reducing risk factors such as cholesterol and blood pressure.
One in three women of reproductive age have at least one chronic condition that could compromise their health or lead to adverse outcomes during pregnancy, according to University of Utah Health scientists.
Science hasn’t yet caught up with electronic cigarettes, leaving health care providers and users with many unknowns. But a new review of the research so far finds growing evidence that vaping can harm the heart and blood vessels.
GRAND RAPIDS, Mich. (Nov. 6, 2019) — Scientists have devised a technique to sort out which heart cells can replicate and which cannot, a critical step toward treatments that may one day help the heart heal itself after injury.
A study by researchers at Icahn School of Medicine at Mount Sinai proposes a novel method for identifying patterns in the frequency and cost of multiple chronic conditions (MCC).
The U.S. Food and Drug Administration (FDA) has awarded AnaBios an exclusive Indefinite Delivery Indefinite Quantity (IDIQ) contract to employ adult human primary tissues and cardiomyocytes from organ donors to assess drug safety related to cardiac function.
Patients struggling with type 2 diabetes and obesity are faced with the decision of whether to receive usual medical care or undergo weight-loss surgery. Now, a new risk calculator developed by Cleveland Clinic researchers can show these patients their risks of developing major health complications over the next 10 years depending on which course of treatment they choose. The research was presented today as one of the Top 10 studies at the ObesityWeek 2019 international conference in Las Vegas.
The annual transition to and from daylight saving time (DST) has clinical implications that last longer than the days where clocks “fall back” or “spring forward.”
Using medical record and survey data collected from more than 3,400 women, Johns Hopkins Medicine researchers have added to evidence that women who have given birth five or more times were more likely than those who had fewer births to have more risk factors for heart disease, including obesity, high blood pressure and inadequate physical activity.
Announcement of a new $15 million gift for University Hospitals to develop a new model for the delivery of health care to men.
An unexplored kinase in heart muscle cells may be a good target to treat heart failure, a disease that is only incrementally delayed by existing therapies. Failing human hearts showed reduced amounts of this kinase, and restoring the amount of this kinase in a kinase-depleted mouse model rescued the animal from heart failure.
A Mayo Clinic-led study involving 488 cardiac patients whose cases were followed for up to 12 years finds that microvascular endothelial dysfunction, a common early sign of cardiovascular disease, is associated with a greater than twofold risk of cancer. The study, published in the European Journal of Preventive Cardiology, finds that microvascular endothelial dysfunction may be a useful marker for predicting risk of solid-tumor cancer, in addition to its known ability to predict more advanced cardiovascular disease, says Amir Lerman, M.D., a Mayo Clinic cardiologist and the study's senior author.
A mother’s exposure to particulate air pollution during pregnancy is associated with reduced cardiac response to stress in six-month-old infants, according to Mount Sinai research published in Environmental Health Perspectives in October. This study is the first to find that particulate air pollution exposure in utero can affect heart rate variability, which is a known risk factor for health issues.
When Mick Jagger received an artificial heart valve via catheter, he made the transcatheter replacement valve famous. Iconic "Dr. Y" made it possible. Ajit Yoganathan's lab has tested every valve on the market for quality, and his analyses shaped the industry and its designs, including of the valve in Jagger's chest.
More than one-third of Americans get less than seven hours of sleep each night, putting them at risk for serious, chronic health conditions such as diabetes, heart disease and obesity. The real victim of a lack of sleep, however, is the brain.
Retired U.S. Army Colonel Norman M. Rich, MD, FACS, DMCC, MC, of Rockville, Md., received the first American College of Surgeons (ACS) Distinguished Military Lifetime Achievement Award last night during the Convocation ceremony that preceded the opening of the College's Clinical Congress 2019.
Middle-aged adults who show symptoms of borderline personality disorder may be at greater risk for a heart attack, as they show physical signs of worsening cardiovascular health more than other adults, according to research published by the American Psychological Association.
Thiazide diuretics demonstrate better effectiveness and cause fewer side effects than ACE inhibitors as first-line antihypertensive drugs, according to a report published Oct. 24 in The Lancet. Marc A. Suchard, MD, PhD, professor of biostatistics at the UCLA Fielding School of Public Health served as lead author.of the study.
A new study of nearly 5 million patients shows the most-popular first-line treatment for hypertension is less effective and causes more side effects than thiazide diuretics.
A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.
Since its inception in 1995, the mission for A Woman’s Journey has remained the same: to empower women to make the right health care decisions for their families and themselves.
Chronic kidney disease, which afflicts an estimated 6.4% of U.S. adults 45 and older, is associated with an increased risk of heart attack and other adverse cardiovascular outcomes, according to new research from Mayo Clinic.
David Eisner has been selected to serve as the eighth editor-in-chief of the Journal of General Physiology (JGP), effective January 1, 2020. Eisner, the British Heart Foundation Professor of Cardiac Physiology at the University of Manchester, succeeds Sharona Gordon, who has led the journal since 2014.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a machine-learning algorithm that gleans information from microscope images—allowing for high-throughput epigenetic drug screens that could unlock new treatments for cancer, heart disease, mental illness and more. The study was published in eLife.
The University of Chicago Medicine, in partnership with the American Heart Association, has installed a hands-only CPR kiosk in the Center for Care and Discovery. It's one of three in Chicago.
Research has shown that while elite athletes overall are at decreased risk of death from cardiovascular problems, a certain group of athletes -- football linemen in the United States
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right